Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.
about
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaBCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case ReportGenotypes Affecting the Pharmacokinetics of Anticancer Drugs.OCT1 and imatinib transport in CML: is it clinically relevant?Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia.Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate.hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia.Advances and challenges in hereditary cancer pharmacogenetics.Pharmacogenetics of drug transporters in modulating imatinib disposition and treatment outcomes in chronic myeloid leukemia & gastrointestinal stromal tumor patients.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.
P2860
Q26781539-3E21E0AC-8492-4827-811B-D5F52A5A846EQ33574738-F684A9CF-FCF6-4408-B308-1C2C1C788A23Q37685527-B238AC0C-A789-4067-896C-5B14FD54512FQ38540022-A9027F6E-26CB-474A-BCAE-9C53B2AB3F16Q38826494-F652A58E-43EB-46A1-9F67-037D796B7EB9Q38843265-9FDBBD17-E86F-441A-957D-9E4B9D4D1B82Q38868934-F9DAF5EB-0B7D-4E8F-B9EE-0A7328254240Q38902116-80FF72AF-5A19-4E85-B5F5-29505AACBE0AQ38948499-57DD4BDF-A3C0-44B9-99D2-7C369C4704D2Q38996487-F9C1F1B7-ADF2-4120-846B-B5E4F12750C5Q39429836-ACF91543-9096-4AFF-8D47-E9AEE1B6301AQ41471555-007A796C-C2EC-48F6-B494-2B49C0F7927DQ45790127-EDA1C966-379D-4C68-AF1A-483F5E35922BQ47216949-3C377074-5BD8-435B-932B-DF4474FB6F33Q47912945-2F9BC697-1D99-4C50-B6EA-5B272A8A7D6FQ49833785-B1B586D8-ADC3-4F56-A2B3-393CAEBBC24DQ53800817-93D785F4-7D41-41AA-8FA1-5D13C062E933
P2860
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@en
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@nl
type
label
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@en
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@nl
prefLabel
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@en
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@nl
P2093
P2860
P921
P1433
P1476
Polymorphisms in the human org ...... with chronic myeloid leukemia.
@en
P2093
Alexander Gural
David Lavie
Deborah Rund
Diana Libster
Dina Ben-Yehuda
Jacob Vine
Moshe E Gatt
Moshe Levin
Neta Goldschmidt
Rosa Ruchlemer
P2860
P304
P356
10.3109/10428194.2014.893307
P577
2014-03-19T00:00:00Z